Laurus Labs Limited (LAURUSLABS) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.222x

Based on the latest financial reports, Laurus Labs Limited (LAURUSLABS) has a cash flow conversion efficiency ratio of 0.222x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs10.93 Billion ≈ $118.22 Million USD) by net assets (Rs49.34 Billion ≈ $533.54 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Laurus Labs Limited to measure how many days the company can operate on defensive assets alone.

Laurus Labs Limited - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Laurus Labs Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Laurus Labs Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Laurus Labs Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Gotion High tech Co Ltd SHE:002074	0.004x
BOK Financial Corporation NASDAQ:BOKF	0.015x
SHIZUOKA FIN. GROUP INC. F:P2U	N/A
Powertech Technology Inc TW:6239	0.073x
Dixon Technologies (India) Limited NSE:DIXON	0.044x
NEMETSCHEK UNSP.ADR/02 F:NEM0	N/A
Rexford Industrial Realty Inc NYSE:REXR	0.017x
EVONIK INDUST.(U.ARD)2 F:EVKA	0.075x

Annual Cash Flow Conversion Efficiency for Laurus Labs Limited (2013–2025)

The table below shows the annual cash flow conversion efficiency of Laurus Labs Limited from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Laurus Labs Limited worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs46.03 Billion ≈ $497.75 Million	Rs6.02 Billion ≈ $65.07 Million	0.131x	-19.18%
2024-03-31	Rs41.16 Billion ≈ $445.08 Million	Rs6.66 Billion ≈ $71.99 Million	0.162x	-34.11%
2023-03-31	Rs40.49 Billion ≈ $437.85 Million	Rs9.94 Billion ≈ $107.49 Million	0.245x	-9.49%
2022-03-31	Rs33.59 Billion ≈ $363.27 Million	Rs9.11 Billion ≈ $98.53 Million	0.271x	-3.76%
2021-03-31	Rs26.01 Billion ≈ $281.26 Million	Rs7.33 Billion ≈ $79.27 Million	0.282x	+43.58%
2020-03-31	Rs17.70 Billion ≈ $191.39 Million	Rs3.47 Billion ≈ $37.57 Million	0.196x	+2.77%
2019-03-31	Rs15.58 Billion ≈ $168.54 Million	Rs2.98 Billion ≈ $32.19 Million	0.191x	-17.32%
2018-03-31	Rs14.83 Billion ≈ $160.34 Million	Rs3.42 Billion ≈ $37.04 Million	0.231x	-7.42%
2017-03-31	Rs13.30 Billion ≈ $143.88 Million	Rs3.32 Billion ≈ $35.90 Million	0.250x	+9.96%
2016-03-31	Rs8.52 Billion ≈ $92.12 Million	Rs1.93 Billion ≈ $20.90 Million	0.227x	+352.81%
2015-03-31	Rs7.21 Billion ≈ $77.96 Million	Rs-647.06 Million ≈ $-7.00 Million	-0.090x	-126.54%
2014-03-31	Rs3.58 Billion ≈ $38.76 Million	Rs1.21 Billion ≈ $13.11 Million	0.338x	-0.57%
2013-03-31	Rs2.59 Billion ≈ $28.04 Million	Rs882.08 Million ≈ $9.54 Million	0.340x	--

About Laurus Labs Limited

NSE:LAURUSLABS India Drug Manufacturers - Specialty & Generic

Market Cap

$8.04 Billion

Rs743.06 Billion INR

Market Cap Rank

#2657 Global

#108 in India

Share Price

Rs1376.40

Change (1 day)

-0.91%

52-Week Range

Rs646.25 - Rs1446.80

All Time High

Rs1446.80